Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma
Abstract Pancreatic adenocarcinoma is a lethal disease that is projected to become the second most common cause of cancer deaths by 2030. The role of adjuvant therapy after surgical resection has been established by several clinical trials to prolong survival and improve outcomes. Multiagent chemoth...
Main Authors: | Sami Shoucair, Andrew R. Baker, Jun Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Annals of Gastroenterological Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ags3.12514 |
Similar Items
-
Prevalence of germline variants in Brazilian pancreatic carcinoma patients
by: Lívia Munhoz Rodrigues, et al.
Published: (2024-09-01) -
Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
by: Noor Muhammad, et al.
Published: (2023-11-01) -
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma
by: Youngil Koh, et al.
Published: (2023-10-01) -
Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing
by: An-Ko Chung, et al.
Published: (2023-05-01) -
Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets
by: Zhang Dong, et al.
Published: (2024-03-01)